Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (9863)	5/9/1999 9:45:00 AM
From: William L. Molair II	Read Replies (2) \| Respond to of 17367

Robert / George /etc. I am starting to wonder if the better investment move, might be to sell XOMA, wait for the announcement, and then make a decision whether or not to repurchase shares? Given the lack of investor interest in biotechs (especially small ones), even if the news is good, Xoma stock may trade up some on positive mengio news - but still may offer a decent reentry point. If the news is bad or ho-hum, we could see sub $1 per share. Comments / Thoughts / and Opinions appreciated ...

To: Robert K. who wrote (9863)	5/9/1999 11:42:00 AM
From: aknahow	Respond to of 17367

Bob, I held back on posting that one because of the date. To avoid being scooped by you again I am posting this one, now. Am sure by the time of this meeting those of us that are still alive will have heard something about XOMA, if it too is still alive. March 4th 2100 105th World Congress on Trauma, Shocking, and Inflammatory Post and Sepsis - Scientific Committee Scientific Program Invited Speakers Secretariat Tentative Topics Join us in 2100 Excerpt of Invited Speakers and Chairmen B. Beutler III, Dallas, USA J. Castello II, Bermuda, UK S. Carrol IV, Bermuda, UK T. Dude III, Texas USA Brenda Giroir, Dallas, USA B. Green, USA S.M. Opalapril, IV Pawtucket, USA